International Clinical Trial: RISE-VR Prevent

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00040837) titled 'RISE-VR Prevent' on Sept. 3.

Study Type: interventional

Study Design: Allocation: Randomized controlled study Masking: Blinded (masking used) Control: No treatment / Standard of care Assignment: parallel Study design purpose: prevention

Primary Sponsor: Professur fur Klinische Psychologie und Psychotherapie des Kindes- und Jugendalters

Condition: F32 F41 F33 Depressive episode Other anxiety disorders Recurrent depressive disorder

Intervention: Group 1: Virtual Reality Application RISE-VR Group 2: Waitlist Control Group....

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 15/09/2...